Patent details

EP1423419 Title: HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS

Basic Information

Publication number:
EP1423419
PCT Application Number:
PCT/IB/2002/003904
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027775923
PCT Publication Number:
WO/2003/020756
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
HYBRID AND TANDEM EXPRESSION OF NEISSERIAL PROTEINS
French Title of Invention:
EXPRESSION HYBRIDE ET EN TANDEM DE PROTEINES DE NEISSERIA
German Title of Invention:
HYBRID UND TANDEMPROTEINE VON NEISSERIA SP
SPC Number:

Dates

Filing date:
06/09/2002
Grant date:
19/01/2011
EP Publication Date:
19/01/2011
PCT Publication Date:
13/03/2003
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
02/06/2004
EP B1 Publication Date:
19/01/2011
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/09/2018
Expiration date:
06/09/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/03/2018
 
 

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

History of Owners

From:
06/09/2002
To:
26/02/2018

Name:
Novartis Vaccines and Diagnostics S.r.l.
Address:
Via Fiorentina 1, 53100 Siena (SI), Italy (IT)

Agent

1

Name:
KIRKPATRICK SA/NV Intellectual Property
From:
27/02/2018
Address:
Avenue Wolfers 32, 1310, LA HULPE, Belgium (BE)
To:

2

Name:
OFFICE FREYLINGER S.A.
From:
02/02/2011
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
PIZZA Mariagrazia Chiron S.p.A.
Address:
Italy (IT)

Priority

Priority Number:
0121591
Priority Date:
06/09/2001
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07K 14/22;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2018/05
Publication date:
11/04/2018
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20180000090A
Date Registered:
09/03/2018
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
MARKS & CLERK (Luxembourg) LLP
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
GlaxoSmithKline Biologicals SA
Address:
Rue de l'Institut 89, 1330 Rixensart, Belgium (BE)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
14/09/2017
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
MDC (HENKEL PATENT)
Filing date Document type Number of pages
14/03/2018 Outgoing Correspondence 1
30/01/2019 Outgoing Correspondence 1
27/02/2018 Power Of Attorney 9
09/03/2018 Outgoing Correspondence 1
09/03/2018 Request For Change 9